Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume 11, Issue 8, Pages 795-801
Publisher
Wiley
Online
2009-07-24
DOI
10.1093/eurjhf/hfp098
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
- (2009) Marc A. Pfeffer et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of darbepoetin α on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
- (2008) John T. Parissis et al. AMERICAN HEART JOURNAL
- Darbepoetin-α prevents progressive left ventricular dysfunction and remodeling in nonanemic dogs with heart failure
- (2008) Sharad Rastogi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Tumor Progression Associated with Erythropoiesis-Stimulating Agents
- (2008) Ashley M Newland et al. ANNALS OF PHARMACOTHERAPY
- Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia
- (2008) Jalal K. Ghali et al. CIRCULATION
- Erythropoiesis-Stimulating Agent Use in Cancer: Preclinical and Clinical Perspectives
- (2008) M. O. Arcasoy CLINICAL CANCER RESEARCH
- Effects of darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure
- (2008) Kallirrhoe Kourea et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- Heart failure and anemia: mechanisms and pathophysiology
- (2008) Inder S. Anand HEART FAILURE REVIEWS
- Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
- (2008) Robert E. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation and Long-Term Prognosis of New-Onset, Transient, and Persistent Anemia in Ambulatory Patients With Chronic Heart Failure
- (2008) W.H. Wilson Tang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anemia and Mortality in Heart Failure Patients
- (2008) Hessel F. Groenveld et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure
- (2007) Kallirrhoe Kourea et al. ATHEROSCLEROSIS
- Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update
- (2007) J. Douglas Rizzo et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
- (2007) Karien van der Putten et al. Nature clinical practice. Nephrology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started